Topic
Neoadjuvant Chemotherapy
3 Podcasts on BackTable
Hear how experienced physicians approach Neoadjuvant Chemotherapy on BackTable. Learn from podcasts, cases, and courses curated by physician content creators, covering patient selection, workup, and procedure technique. Get the BackTable app to follow this Topic and hear more of the conversations that matter to your practice.
Episode # 45 • 27 Jan 2026
Urothelial Carcinoma: Understanding ctDNA & Precision Medicine
Is the era of cisplatin over, or are we simply becoming more precise about who benefits from it? As perioperative strategies in bladder cancer continue to evolve, emerging tools like circulating tumor DNA (ctDNA) are playing a bigger role in how clinicians assess recurrence risk and tailor treatment. In this episode of BackTable Tumor Board, host Alan Tan, medical oncologist at Vanderbilt-Ingram Cancer Center, is joined by bladder cancer experts Dr. Amanda Nizam and Dr. Brad McGregor to discuss recent advances in the diagnosis and treatment of urothelial carcinoma.
More on Neoadjuvant Chemotherapy
Tumor Board Episode #45
Jan 27, 2026
with Dr. Amanda Nizam, Dr. Brad McGregor, Dr. Alan Tan
Is the era of cisplatin over, or are we simply becoming more precise about who benefits from it? As perioperative...
180+ listens
Urology Episode #280
Dec 16, 2025
with Dr. Carissa Chu, Dr. Ruchika Talwar
Can genomic classifiers close the gap between what we see and what a tumor will do? In this episode of BackTable...
1,100+ listens
Tumor Board Episode #42
Jan 6, 2026
with Dr. Rebecca Snyder, Dr. Jonathan Mizrahi
For the small subset of pancreatic cancer patients whose cancer is detected early and remains localized, there are now...
180+ listens
The Materials available on BackTable are provided for informational and educational purposes only and are not a substitute for the independent professional judgment of a qualified healthcare professional in diagnosing or treating patients. Any opinions, statements, or views expressed are those of the individual contributors and do not necessarily reflect those of the publisher, platform, or any affiliated organization.